These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 23952513)

  • 1. Puzzling about opiate substitution therapy: a synopsis and commentary.
    Adrian M
    Subst Use Misuse; 2013 Aug; 48(11):1022-3. PubMed ID: 23952513
    [No Abstract]   [Full Text] [Related]  

  • 2. Piecing together stakeholder puzzles-puzzling about (opioid substitute treatment---OST) stakeholders and their pieces: a rambling point-of-view.
    Einstein S
    Subst Use Misuse; 2013 Aug; 48(11):1024-58. PubMed ID: 23952514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Commentary on Degenhardt et al. (2014): Access to opioid substitution therapy in prison is not enough-the crucial role of post-release retention in preventing drug-related harms.
    Stoové M; Kinner S
    Addiction; 2014 Aug; 109(8):1318-9. PubMed ID: 25041202
    [No Abstract]   [Full Text] [Related]  

  • 4. Commentary on "Substitution treatment in the era of 'recovery': an analysis of stakeholder roles and policy windows in Britain".
    Neale J
    Subst Use Misuse; 2013 Aug; 48(11):1059-60. PubMed ID: 23952515
    [No Abstract]   [Full Text] [Related]  

  • 5. Commentary on Irmgard Eisenbach-Stangl, deviance or innovation? Recent changes of drug substitution treatment policy in Austria.
    Malinowska-Sempruch K
    Subst Use Misuse; 2013 Aug; 48(11):1061-2. PubMed ID: 23952516
    [No Abstract]   [Full Text] [Related]  

  • 6. Commentary on Vibeke Asmussen Frank, Bagga Bjerge, and Esben Houborg: Medicalization can be beneficial, but is no guarantee for user influence.
    Stenius K
    Subst Use Misuse; 2013 Aug; 48(11):1069-70. PubMed ID: 23952520
    [No Abstract]   [Full Text] [Related]  

  • 7. Commentary on Jacek Moskalewicz and Marta Welbel, Walking through mud; history of the Polish methadone maintenance treatment from its stakeholders' perspective.
    Malinowska-Sempruch K
    Subst Use Misuse; 2013 Aug; 48(11):1063-4. PubMed ID: 23952517
    [No Abstract]   [Full Text] [Related]  

  • 8. Commentary on Holland et al. (2014): Opioid maintenance treatment--how much supervision is helpful?
    Koller G
    Addiction; 2014 Apr; 109(4):608-9. PubMed ID: 24605959
    [No Abstract]   [Full Text] [Related]  

  • 9. Commentary on "Stakeholders' role in contemporary 'substitute drug' prescribing policies in Italy" by Franca Beccaria and Sara Rolando.
    Minutillo A; Zuccaro P
    Subst Use Misuse; 2013 Aug; 48(11):1065-6. PubMed ID: 23952518
    [No Abstract]   [Full Text] [Related]  

  • 10. Commentary on Burns et al. (2015): retention in buprenorphine treatment.
    Saxon AJ
    Addiction; 2015 Apr; 110(4):656-7. PubMed ID: 25771691
    [No Abstract]   [Full Text] [Related]  

  • 11. Opioid substitution treatment in Tihar prisons, India: Process of implementation.
    Jhanjee S; Pant S; Girdhar NK; Sethi H; Gunasekaran Rengaswamy R; Jain R; Sarangi J
    Int J Drug Policy; 2015 Sep; 26(9):890-1. PubMed ID: 26123894
    [No Abstract]   [Full Text] [Related]  

  • 12. Hepatitis B vaccination in clients attending for opiate replacement therapy: opportunism is key.
    Bailey SM; Oomkens B; Gilles MT
    Drug Alcohol Rev; 2013 Sep; 32(5):550-1. PubMed ID: 23763638
    [No Abstract]   [Full Text] [Related]  

  • 13. Tracing the justifications of opioid maintenance treatment in Finland.
    Selin J
    Subst Use Misuse; 2013 Aug; 48(11):1067-8. PubMed ID: 23952519
    [No Abstract]   [Full Text] [Related]  

  • 14. Comparison table: some drugs for maintenance treatment of opioid use disorder.
    Med Lett Drugs Ther; 2017 May; 59(1521):e96-e97. PubMed ID: 28609422
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of Opioid-Use Disorders.
    Schuckit MA
    N Engl J Med; 2016 Jul; 375(4):357-68. PubMed ID: 27464203
    [No Abstract]   [Full Text] [Related]  

  • 16. Opioid pharmacotherapy in criminal justice settings: now is the time.
    Lee JD; Rich JD
    Subst Abus; 2012; 33(1):1-4. PubMed ID: 22263707
    [No Abstract]   [Full Text] [Related]  

  • 17. Drugs for opioid Use disorder.
    Med Lett Drugs Ther; 2017 Jun; 59(1522):89-95. PubMed ID: 28609420
    [No Abstract]   [Full Text] [Related]  

  • 18. Use and misuse of opioid agonists in opioid addiction.
    Modesto-Lowe V; Swiezbin K; Chaplin M; Hoefer G
    Cleve Clin J Med; 2017 May; 84(5):377-384. PubMed ID: 28530896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exercise as an adjuvant intervention in opiate dependence.
    Pareja-Galeano H; Sanchis-Gomar F; Mayero S
    Subst Abus; 2013; 34(2):87-8. PubMed ID: 23577897
    [No Abstract]   [Full Text] [Related]  

  • 20. Methadone is no panacea.
    Spence D
    BMJ; 2012 Aug; 345():e5670. PubMed ID: 22915733
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.